Pancreatic Cancer Research

Journal articleClin Lab2019

Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer.

Journal
Clin Lab
Published
1 November 2019
Citations
11
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background The current study aims to explore the clinical value of serum miR-499a-5p in the diagnosis of pancreatic cancer. Methods One hundred twenty-four patients with pancreatic cancer (cancer group), 100 patients with benign pancreatic diseases (benign control group), and 100 healthy people (healthy control group) were selected as the observation objects from January 2017 to June 2017. … Excerpt only: this text is the publisher’s. Read it in full at the source.